Innovotech Inc. (TSXV:IOT)
Canada
· Delayed Price · Currency is CAD 0.208
+0.007 (3.75%)
At close: Apr 28, 2026
Innovotech Revenue
In the year 2025, Innovotech had annual revenue of 4.53M CAD with 106.65% growth. Innovotech had revenue of 1.12M in the quarter ending December 31, 2025, with 7.54% growth.
Revenue
4.53M
Revenue Growth
+106.65%
P/S Ratio
2.49
Revenue / Employee
283.43K
Employees
16
Market Cap
11.30M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 4.53M | 2.34M | 106.65% |
| Dec 31, 2024 | 2.19M | 1.01M | 85.56% |
| Dec 31, 2023 | 1.18M | 56.82K | 5.05% |
| Dec 31, 2022 | 1.13M | -355.95K | -24.02% |
| Dec 31, 2021 | 1.48M | 288.39K | 24.17% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Glow Lifetech | 2.05M |
| COSCIENS Biopharma | 10.28M |
| Rapid Dose Therapeutics | 2.78M |
| Britannia Life Sciences | 157.68K |
| Pharmala Biotech Holdings | 889.57K |
| Kane Biotech | 427.87K |
Innovotech News
- 14 days ago - Innovotech Inc. Begins Trading on OTCQB Under Symbol IOTCF, Expanding Access for U.S. Investors - TheNewswire
- 6 months ago - Innovotech (IOT:CA) Launches $200,000 Convertible Debenture Offering - GuruFocus